Rockwell Medical (RMTI) Reports Q1 Loss of $0.84/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
May 16, 2022 4:02 PM EDT- First quarter net sales of $16.1 million, up 4.2% year-over-year -Â
- Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Trial -
- Amended and expanded supply agreement with DaVita, including $7.5M investment, strengthens Rockwell's financial position, laying groundwork for profitable concentrates business -
- Completion of patient enrollment ahead of schedule in pivotal Phase 3 trial of Triferic® in China -
- Conference call and webcast scheduled for today at 4:15 p.m. ET... More
